Accreditation Information
This activity is jointly provided by Medical Education Resources and HMP Education in collaboration with Meeting Designs, LLC. This activity is supported by an educational grant from Eli Lilly.
Target Audience
Dermatologists, as well as specialists in other therapeutic areas, e.g., gastroenterology, rheumatology, dermatology, surgery, gynecologists, urologists, plastic surgeons, emergency room health care providers, and primary care physicians including pediatricians.
Program Overview
This activity will consist of didactic lectures, interactive panel talks and audience Q&A.
Learning Outcomes
To include the variety of issues the target audience and healthcare team face that may contribute to the practice gaps. Barriers may be a variety of issues including but not limited to systems barriers, cost, patient adherence, time, reimbursement, etc.
Educational Objectives
After completing this activity, the participant should be better able to:
- Assess the prevalence of metabolic comorbidities in patients with psoriatic disease and their impact on morbidity and mortality
- Implement current guidelines for the assessment and management of PsO/PsA and associated metabolic comorbidities, including obesity, diabetes, cardiovascular disease, and dyslipidemia
- Evaluate the role of GLP-1R agonists in the management of MetS in patients with PsO/PsA
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and HMP Education. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation
Medical Education Resources designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC) Credit Designation
Medical Education Resources designates this live activity for a maximum of 1.25 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.
American Academy of Nurse Practitioners (ANNP) Credit Designation
The American Academy of Nurse Practitioners (AANP) Certification Board recognizes and accepts continuing education (CE) 1.25 contact hours from activities approved by AMA, ACCME, ANCC, AANP.
Physician Associates Credit Designation
Medical Education Resources has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME Credits. Physician Associates should only claim credit commensurate with the extent of their participation.
Disclosure of All Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high‐quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
The authors reported the following financial relationships with ineligible companies whose products or services may be mentioned in this activity:
Alice Gottlieb, MD, PhD: Grants/Research Support - Highlights Therapeutics, Bristol Myers Squibb, Janssen, UCB Pharma; Consulting Fees - Amgen, AnaptysBio, Avotres Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Dice Therapeutics, Eli Lilly, Highlights Therapeutics, Janssen, Novartis, Sanofi, Sun Pharma, UCB Pharm and Xbiotech; Stock Options/Shareholder - RA Project
Joseph Merola, MD, MMSc: Grants/Research Support - Leo, Novartis, Pfizer, Sanofi, UCB, Biogen; Consulting Fees - Abbvie, Biogen, Amgen, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Merck, Novartis, Pfizer, Sanofi, UCB, Bristol‐Myers‐Squibb
Brittany Weber, MD, PhD: Consulting Fees - Novo Nordisk Inc., Kiniksa Pharmaceuticals, Horizon, BMS
The content managers have no relationships to report.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, HMP Education and/or Eli Lilly. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
This activity is jointly provided by Medical Education Resources and HMP Education in collaboration with Meeting Designs, LLC. This activity is supported by an educational grant from Eli Lilly.
Target Audience
Dermatologists, as well as specialists in other therapeutic areas, e.g., gastroenterology, rheumatology, dermatology, surgery, gynecologists, urologists, plastic surgeons, emergency room health care providers, and primary care physicians including pediatricians.
Program Overview
This activity will consist of didactic lectures, interactive panel talks and audience Q&A.
Learning Outcomes
To include the variety of issues the target audience and healthcare team face that may contribute to the practice gaps. Barriers may be a variety of issues including but not limited to systems barriers, cost, patient adherence, time, reimbursement, etc.
Educational Objectives
After completing this activity, the participant should be better able to:
- Assess the prevalence of metabolic comorbidities in patients with psoriatic disease and their impact on morbidity and mortality
- Implement current guidelines for the assessment and management of PsO/PsA and associated metabolic comorbidities, including obesity, diabetes, cardiovascular disease, and dyslipidemia
- Evaluate the role of GLP-1R agonists in the management of MetS in patients with PsO/PsA
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and HMP Education. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation
Medical Education Resources designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC) Credit Designation
Medical Education Resources designates this live activity for a maximum of 1.25 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.
American Academy of Nurse Practitioners (ANNP) Credit Designation
The American Academy of Nurse Practitioners (AANP) Certification Board recognizes and accepts continuing education (CE) 1.25 contact hours from activities approved by AMA, ACCME, ANCC, AANP.
Physician Associates Credit Designation
Medical Education Resources has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME Credits. Physician Associates should only claim credit commensurate with the extent of their participation.
Disclosure of All Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high‐quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
The authors reported the following financial relationships with ineligible companies whose products or services may be mentioned in this activity:
Alice Gottlieb, MD, PhD: Grants/Research Support - Highlights Therapeutics, Bristol Myers Squibb, Janssen, UCB Pharma; Consulting Fees - Amgen, AnaptysBio, Avotres Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Dice Therapeutics, Eli Lilly, Highlights Therapeutics, Janssen, Novartis, Sanofi, Sun Pharma, UCB Pharm and Xbiotech; Stock Options/Shareholder - RA Project
Joseph Merola, MD, MMSc: Grants/Research Support - Leo, Novartis, Pfizer, Sanofi, UCB, Biogen; Consulting Fees - Abbvie, Biogen, Amgen, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Merck, Novartis, Pfizer, Sanofi, UCB, Bristol‐Myers‐Squibb
Brittany Weber, MD, PhD: Consulting Fees - Novo Nordisk Inc., Kiniksa Pharmaceuticals, Horizon, BMS
The content managers have no relationships to report.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, HMP Education and/or Eli Lilly. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.